Archive for the ‘research’ Category

Finally Confirmed! Vitamin D Nearly Abolishes ICU Risk in COVID-19

https://chrismasterjohnphd.com/covid-19/finally-confirmed-vitamin-d-nearly-abolishes-icu-risk-in-covid-19

Finally Confirmed! Vitamin D Nearly Abolishes ICU Risk in COVID-19

By Chris Masterjohn PhD, Nutritional Science

September 3, 2020

The first randomized controlled trial (RCT) of vitamin D in COVID-19 has just been published. The results are astounding: vitamin D nearly abolished the odds of requiring treatment in ICU. Although the number of deaths was too small to say for sure, vitamin D may actually abolish the risk of death from COVID-19.

The Vitamin D Treatment Protocol

The vitamin D was provided as oral calcifediol, also known as calcidiol, 25(OH)D, and 25-hydroxyvitamin D.  The treatment in this RCT was soft capsules of 532 mcg 25(OH)D on day 1 of admission to the hospital, followed by 266 mcg on days 3 and 7, and then 266 mcg once a week until discharge, ICU admission, or death.

This is equivalent to 106,400 IU vitamin D on day 1, 53,200 IU on days 3 and 7, and 53,200 IU weekly thereafter. If this were given as daily doses, it would be the equivalent of 30,400 per day for the first week, followed by a maintenance dose of 7,600 IU per day.

Version 6 of the Food and Supplement Guide for the Coronavirus

I have now released Version 6 of The Food and Supplement Guide for the Coronavirus to reflect the new study on vitamin D. Purchases of the guide are greatly appreciated, as they help sustain my work on this newsletter and will help me start finishing my Vitamins and Minerals 101 book. (See link for article)

_____________________

For more:  https://madisonarealymesupportgroup.com/2020/07/29/researchers-investigating-possible-link-between-vitamin-d-deficiency-and-covid-19/

https://madisonarealymesupportgroup.com/2020/07/07/why-you-may-need-more-vitamin-d-especially-now/

https://madisonarealymesupportgroup.com/2018/03/12/the-importance-of-vitamin-d-k-and-magnesium-for-lyme-msids-patients/

https://madisonarealymesupportgroup.com/2020/07/02/experts-criticize-government-review-of-vitamin-d-for-covid-19/

 

Human Babesiosis: Recent Advances & Future Challenges

doi: 10.1097/MOH.0000000000000606. Online ahead of print.

Human babesiosis: recent advances and future challenges

Affiliations expand
Abstract

Purpose of review: As human babesiosis caused by apicomplexan parasites of the Babesia genus is associated with transfusion-transmitted illness and relapsing disease in immunosuppressed populations, it is important to report novel findings relating to parasite biology that may be responsible for such pathology. Blood screening tools recently licensed by the FDA are also described to allow understanding of their impact on keeping the blood supply well tolerated.

Recent findings: Reports of tick-borne cases within new geographical regions such as the Pacific Northwest of the USA, through Eastern Europe and into China are also on the rise. Novel features of the parasite lifecycle that underlie the basis of parasite persistence have recently been characterized. These merit consideration in deployment of both detection, treatment and mitigation tools such as pathogen inactivation technology. The impact of new blood donor screening tests in reducing transfusion transmitted babesiosis is discussed.

Summary: New Babesia species have been identified globally, suggesting that the epidemiology of this disease is rapidly changing, making it clear that human babesiosis is a serious public health concern that requires close monitoring and effective intervention measures. Unlike other erythrocytic parasites, Babesia exploits unconventional lifecycle strategies that permit host cycles of different lengths to ensure survival in hostile environments. With the licensure of new blood screening tests, incidence of transfusion transmission babesiosis has decreased.

_____________________

https://www.medscape.com/viewarticle/934602

Rise in Babesiosis Cases, Pennsylvania, USA, 2005–2018

David Ingram; Tonya Crook

Emerging Infectious Diseases. 2020;26(8):1703-1709. 

Abstract

Babesiosis is an emerging infection in the state of Pennsylvania, and clinicians need to be made aware of its clinical manifestations as well as the risk factors associated with severe disease. Before 2010, our tertiary academic center in central Pennsylvania previously saw zero cases of babesiosis. We saw our first confirmed case of Babesia infection acquired in Pennsylvania in 2011; we recorded 2 confirmed cases in 2017 and 4 confirmed cases in 2018. All 4 cases from 2018 were thought to be acquired in southcentral Pennsylvania counties, whereas prior reports of cases were predominately in the southeast and northeast counties of the state.

_________________

**Comment**

Out of 352 patients in the second study, some of which were duplicates, they reviewed patient charts and only identified 8 cases using CDC criteria.  This continues to be a problem as CDC testing misses many cases, and many do not meet the stringent criteria which in many cases is arbitrary.  The study also noted that there were inconsistencies in the way blood smears and PCR testing were ordered.  

Important to note: most were immunocompetent.

Symptoms(numbers in parenthesis show how many patients had it):

  • fever (6/8) 
  • malaise (5/8)
  • myalgias or arthralgias (2/8)
  • anorexia (2/8),
  • rash (1/8),
  • headache (1/8),
  • nausea or vomiting (1/8)
  • diarrhea (1/8)
  • respiratory failure (1/8)

The most common laboratory abnormalities:

  • anemia (seen in all patients)
  • thrombocytopenia (7/8)
  • transaminitis (7/8) – high liver counts can lead to liver damage
  • hyperbilirubinemia (7/8) excess bilirubin can cause jaundice
Importantly: concurrent Lyme disease was noted in half (4/8) of patients.

Patients were screened for Lyme disease by using ELISA; if the result was positive, then a Western blot was performed. Patients had Lyme disease diagnosed if they had positive ELISA results and positive IgM or IgG results on Western blot.

I can guarantee you more patients had Lyme but were omitted due to abysmal testing. This has been going on for over 40 years.

Six of the 8 patients were classified as having severe infection with parasitemia >10%. Four of the 6 patients with severe infection had co-infection with Borrelia burgdorferi (Lyme disease). The 2 nonsevere patients did not have co-infection.

This agrees with previous findings that concurrent infection makes for more severe disease for a longer duration of time:  https://madisonarealymesupportgroup.com/category/babesia-treatment/

  • Most (7/8) patients received a combination of azithromycin and atovaquone 
  • 3 received clindamycin and quinine.  Of these 3 patients, 1 patient received clindamycin and quinine alone for the duration of their therapy, and 2 patients were switched to azithromycin and atovaquone because of persistent parasitemia. Two of the patients who received clindamycin and quinine (1 of whom was switched to azithromycin and atovaquone) also required blood or platelet transfusions. Five patients underwent red cell exchange transfusions.
  • Average duration of treatment was 18.1 days. The average duration of parasitemia was 9 days.
  • They only had exact date of clearance for 3 of the 8 patients

The authors admit that due to focusing on specific Babesia-related codes, they probably missed patients that were co-infected.  

Once again they erroneously bring up the climate as a factor in tick expansion (therefore disease expansion).  This has been proven to be a faulty assumption:  https://madisonarealymesupportgroup.com/2018/11/07/ticks-on-the-move-due-to-migrating-birds-and-photoperiod-not-climate-change/

They correctly state there is a steady rise in Babesia throughout the U.S.  They also state that the geographic spread could be favored by prior establishment of Lyme disease and that coinfection in mouse reservoirs increases Babesia transmission.

They also rightly maintain:

clinicians must maintain a high index of suspicion in patients with a nonspecific febrile syndrome despite absence of tick bite history or lack of an immunocompromising condition. Evaluation for co-infections, particularly co-infection with B. burgdorferi, should be considered given patients with co-infection appear to have more severe disease.

Herein lies the problem.  Testing for all of this remains abysmal.  Without accurate tests most doctors are just going continue to say, “It’s all in your head.”  And they will continue to get away with it.  

Most mainstream doctors are not even considering coinfection and continue to view this through a myopic tunnel-vision where they believe people are only infected with one pathogen.  

 

 

 

 

 

Lyme Disease Misdiagnosed as Shingles

https://danielcameronmd.com/lyme-disease-misdiagnosed-as-shingles-in-a-62-year-old-man/

LYME DISEASE MISDIAGNOSED AS SHINGLES IN A 62-YEAR-OLD MAN

man with lyme disease and shingles at doctor's office

A recent article, published in the journal Clinical Case Reports, describes the case of a 62-year-old man, from Norway, who was initially diagnosed with shingles, a viral infection which produces a painful skin rash with blisters in a localized area on the body. [1] Shingles, also known as herpes zoster, is common in older individuals who have had chickenpox.

According to Hansen and colleagues, the patient was admitted to the emergency department complaining of epigastric pain that had been ongoing for 4 to 5 weeks. “He described a constant pain with episodic worsening,” writes Hansen. The pain began with a rash in the man’s right upper quadrant area.

Physicians considered several diagnoses. The man had a history of migraines, anxiety, colon polyps, and had been treated for gastroesophageal reflux disease (GERD). Small gallbladder stones were present but were not acute.

The man was diagnosed with shingles and prescribed acyclovir and pregabalin. Despite treatment, he remained ill. His pain increased and “he developed additional symptoms including nausea, lethargy, decreased appetite, constipation, decreased size and force of the urinary stream, and a 5–7 kg weight loss,” writes Hansen.

Imaging and lab tests were negative and the man was discharged. However, one week later, he was re-admitted to the hospital because “his general practitioner did not find it reasonable that his anxiety could explain his current symptoms,” says Hansen.

The man lived in an area endemic for Lyme disease. Although he did not recall a recent tick bite, he had been bitten previously, so serologic tests for Lyme disease were performed. Because his titers of B. burgdorferi IgG were so high and he had a history of tick bites and a rash, a lumbar puncture was ordered. Results were positive.

The 62-year-old man was diagnosed with Lyme disease. His symptoms, except for fatigue, resolved after a 3-week course of IV ceftriaxone. “His weight is now normalized and he has no problems with constipation,” explains Hansen. “The abdominal pain is almost gone. His main problem is fatigue but this is gradually improving.”

The authors point out that atypical clinical presentations of Lyme disease can occur, including gastrointestinal manifestations because of autonomous dysfunction, as was seen in this case.

References:
  1. Hansen BA, Finjord T, Bruserud O. Autonomous dysfunction in Lyme neuroborreliosis. A case report. Clin Case Rep. 2018;6(5):901-903.

Bartonella Found in Ticks, Biting Midges, and Moose

https://pubmed.ncbi.nlm.nih.gov/32757355/

. 2020 Aug 5.

doi: 10.1111/tbed.13762. Online ahead of print.

Bartonella spp. detection in ticks, Culicoides biting midges and wild cervids from Norway

Affiliations expand

Abstract

Bartonella spp. are fastidious, gram-negative, aerobic, facultative intracellular bacteria that infect humans, and domestic and wild animals. In Norway, Bartonella spp. have been detected in cervids, mainly within the distribution area of the arthropod vector deer ked (Lipoptena cervi). We used PCR to survey the prevalence of Bartonella spp. in blood samples from 141 cervids living outside the deer ked distribution area (moose [Alces alces, n = 65], red deer [Cervus elaphus, n = 41] and reindeer [Rangifer tarandus, n = 35]), in 44 pool samples of sheep tick (Ixodes ricinus, 27 pools collected from 74 red deer and 17 from 45 moose) and in biting midges of the genus Culicoides (Diptera: Ceratopogonidae, 120 pools of 6,710 specimens). Bartonella DNA was amplified in moose (75.4%, 49/65) and in red deer (4.9%, 2/41) blood samples. All reindeer were negative. There were significant differences in Bartonella prevalence among the cervid species.

Additionally, Bartonella was amplified in two of 17 tick pools collected from moose and in 3 of 120 biting midge pool samples. The Bartonella sequences amplified in moose, red deer and ticks were highly similar to B. bovis, previously identified in cervids. The sequence obtained from biting midges was only 81.7% similar to the closest Bartonella spp.

We demonstrate that Bartonella is present in moose across Norway and present the first data on northern Norway specimens. The high prevalence of Bartonella infection suggests that moose could be the reservoir for this bacterium.

This is the first report of bacteria from the Bartonella genus in ticks from Fennoscandia and in Culicoides biting midges worldwide.

___________________

**Comment**

Many Lyme patients also have Bartonella.  It is an under-appreciated pathogen:  https://madisonarealymesupportgroup.com/2019/04/24/human-bartonellosis-an-underappreciated-public-health-problem/

It can cause schizophrenia-like symptoms:  https://madisonarealymesupportgroup.com/2019/03/21/bartonella-sudden-onset-adolescent-schizophrenia-a-case-study/

Again, our ‘authorities’ have pigeon-holed Lyme into a singular illness when for many there are numerous pathogens at play, not to mention other important issues like MCAS and mold that need to be dealt with. Also, most doctors are taught that Bartonella is not a big deal and the immune system will just deal with it.  I’ve lost count of how many articles have crossed my desk showing just the opposite to be true.  Bartonella can kill.

Can Lyme Disease Cause Dementia?

https://danielcameronmd.com/can-lyme-disease-cause-dementia/

CAN LYME DISEASE CAUSE DEMENTIA?

can lyme disease cause dementia

There have been reports of Borrelia burgdorferi (Bb), the bacterial agent of Lyme disease, triggering primary dementia, such as Alzheimer’s disease. Researchers who examined the records of 1,594 patients with dementia found that 1.25% had a positive intrathecal anti-Borrelia antibody index (AI), specific for neuroborreliosis. They concluded,

“Pure Lyme dementia exists and has a good outcome after antibiotics.” 1

In a retrospective study, entitled “Secondary dementia due to Lyme neuroborreliosis,” Kristoferitsch and colleagues describe several case reports of patients diagnosed with dementia-like syndromes due to Lyme neuroborreliosis or Lyme disease.2

Rapid improvement with antibiotic treatment

The authors’ case report featuring a 76-year-old woman demonstrates how Lyme disease can cause dementia-like symptoms. The patient developed progressive cognitive decline, loss of weight, nausea, gait disturbance and tremor over a 12-month period. She was referred to a neurology clinic for evaluation.

Three months earlier, the woman had been diagnosed with tension headaches and a depressive disorder. Medications, however, did not improve her symptoms.

Further testing revealed bilateral white matter lesions and an old lacunar lesion located at the left striatum. Extensive neurocognitive testing found “a severe decline of attention, memory and executive functions corresponding to subcortical dementia,” the authors write.

“LNB [Lyme neuroborreliosis] was diagnosed when further CSF [cerebral spinal fluid] examinations disclosed a highly elevated Bb-specific-AI indicating local intrathecal Bb-specific antibody synthesis,” Kristoferitsch writes.

After a 3-week course of treatment with ceftriaxone, the woman “recovered rapidly,” the authors write.

“In a telephone call in February 2018 at the age of 82 years, the patient reported no gait problems or cognitive impairment and had just returned from a trip to Cuba,” the authors write.

Woman admitted to psychiatric ward with severe dementia

A 71-year-old woman with rapidly progressing dementia and short periods of altered consciousness was admitted to a psychiatric hospital. Six months earlier, she was having mild forgetfulness.

MRI results, which indicated slight mesiotemporal atrophy, along with neurocognitive testing supported an initial diagnosis of primary dementia.

“Later, the patient’s daughter reported a tick bite followed by a widespread rash,” the authors write. “Thus, LNB [Lyme neuroborreliosis] was suspected and confirmed by CSF investigations.”

After 2 weeks of antibiotic treatment with ceftriaxone, the woman’s symptoms subsided and her cognition improved.

READ MORE: 80-year-old man with Lyme encephalopathy instead of dementia

At her 5-year follow-up visit, the woman’s “cognition was stable” and memory tests indicated a score above the mean for females her age, “which strongly argued against any dementing process,” the authors write.

In reviewing the literature, Kristoferitsch et al. identified several signs and symptoms that may indicate that Lyme neuroborreliosis (or Lyme disease) is causing dementia in a patient.

Distinguishing features of Lyme-induced dementia

  • Most of the patients or family members did not recall previous tick bites, an EM rash or symptoms of Lyme disease. Therefore, when “EM or other characteristic symptoms of early LB 1–2 years before the onset of dementia may if untreated serve as an indicator for chronic LNB.”
  • Unlike most neurodegenerative dementias, dementia caused by Lyme disease appears to progress rapidly, the authors write.
  • Weight loss is another symptom observed in LNB [Lyme neuroborreliosis],” the authors explain. “It is also compatible with the diagnosis of AD [Alzheimer’s disease] but when it occurs in chronic LNB, it can be more pronounced, reaching up to 20 kg/year.” Weight loss in patients with Alzheimer’s disease is less prominent, the authors explain.
  • Headache, nausea, malaise and vomiting are typically not symptoms of degenerative dementias, the authors explain. But, “might be associated with secondary dementia and thus also with chronic LNB [Lyme neuroborreliosis].”
  • Gait disturbances at the onset or early in the disease which was observed in all cases of this study, makes the diagnosis of a probable AD [Alzheimer’s disease] uncertain or unlikely.”

Additionally, “In most patients, improvement of symptoms was reported already within a few days of antibiotic treatment,” Kristoferitsch writes.

Early recognition and treatment is important

The authors stress the importance of recognizing Lyme-induced dementia-like syndromes.

“It is essential to be aware of this manifestation of Lyme neuroborreliosis, because early antibiotic treatment will prevent permanent sequelae that may occur throughout the further course of the untreated disease,” the authors conclude.

References:
  1. Blanc F, Philippi N, Cretin B, et al. Lyme neuroborreliosis and dementia. J Alzheimers Dis. 2014;41(4):1087-1093. doi:10.3233/JAD-130446
  2. Kristoferitsch W, Aboulenein-Djamshidian F, Jecel J, et al. Secondary dementia due to Lyme neuroborreliosis. Wien Klin Wochenschr. 2018;130(15-16):468-478. doi:10.1007/s00508-018-1361-9

____________________

**Comment**

The proof is in the pudding. These patients were given treatment and they immediately improved. This is noted again and again with chronic Lyme patients – yet according to mainstream medicine led by the CDC and IDSA, this is a figment of our imaginations – otherwise known as PTLDS, an acronym they give complicated cases so they don’t have to deal with persistent infection, and therefore lengthy treatment.

It also allows them to continue to attempt to peddle their lucrative vaccine they continue to pull out of the hat every couple of years.

For more:  https://madisonarealymesupportgroup.com/2020/05/16/lyme-disease-awareness-month-kris-kristofferson-was-misdiagnosed-with-alzheimers-memory-loss-was-due-to-ticks/

For more: